Fig. 1
From: Low hepatitis C prevalence in Belgium: implications for treatment reimbursement and scale up

HCV testing strategy and results, 2013–2014 seroprevalence study, Belgium
From: Low hepatitis C prevalence in Belgium: implications for treatment reimbursement and scale up
HCV testing strategy and results, 2013–2014 seroprevalence study, Belgium